BST
EW icon

Bath Savings Trust’s Edwards Lifesciences EW Stock Holding History

Bath Savings Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$729K Sell
8,055
-310
-4% -$26K 0.08% 116
2026
Q1 		$670K Sell
8,365
-40
-0.5% -$3.3K 0.07% 115
2025
Q4 		$717K Sell
8,405
-85
-1% -$6.98K 0.07% 108
2025
Q3 		$660K Sell
8,490
-590
-6% -$46.1K 0.07% 112
2025
Q2 		$710K Sell
9,080
-2,455
-21% -$183K 0.07% 109
2025
Q1 		$836K Sell
11,535
-8,442
-42% -$604K 0.09% 100
2024
Q4 		$1.48M Sell
19,977
-32,577
-62% -$2.28M 0.15% 85
2024
Q3 		$3.47M Sell
52,554
-24,533
-32% -$1.78M 0.34% 59
2024
Q2 		$7.12M Sell
77,087
-9,828
-11% -$870K 0.76% 36
2024
Q1 		$8.31M Sell
86,915
-2,370
-3% -$199K 0.88% 34
2023
Q4 		$6.81M Sell
89,285
-4,185
-4% -$291K 0.76% 37
2023
Q3 		$6.48M Sell
93,470
-3,440
-4% -$276K 0.8% 34
2023
Q2 		$9.14M Sell
96,910
-5,120
-5% -$445K 1.07% 31
2023
Q1 		$8.44M Sell
102,030
-10,105
-9% -$794K 1.04% 32
2022
Q4 		$8.37M Sell
112,135
-615
-0.5% -$47.4K 1.08% 30
2022
Q3 		$9.32M Sell
112,750
-1,450
-1% -$140K 1.3% 27
2022
Q2 		$10.9M Buy
114,200
+85
+0.1% +$8.8K 1.43% 25
2022
Q1 		$13.4M Buy
114,115
+129
+0.1% +$14.5K 1.53% 22
2021
Q4 		$14.8M Buy
113,986
+52
+0% +$6.07K 1.54% 23
2021
Q3 		$12.9M Buy
113,934
+3,061
+3% +$349K 1.49% 25
2021
Q2 		$11.5M Buy
110,873
+3,620
+3% +$341K 1.35% 26
2021
Q1 		$8.97M Buy
107,253
+5,544
+5% +$469K 1.15% 30
2020
Q4 		$9.28M Buy
101,709
+2,247
+2% +$186K 1.22% 27
2020
Q3 		$7.94M Buy
99,462
+7,721
+8% +$602K 1.3% 27
2020
Q2 		$6.34M Buy
91,741
+5,500
+6% +$391K 1.15% 31
2020
Q1 		$5.42M Buy
86,241
+3,954
+5% +$285K 1.17% 31
2019
Q4 		$6.4M Buy
82,287
+756
+0.9% +$59K 1.16% 30
2019
Q3 		$5.98M Buy
81,531
+168
+0.2% +$11.8K 1.15% 31
2019
Q2 		$5.01M Buy
81,363
+5,847
+8% +$354K 1% 35
2019
Q1 		$4.82M Buy
75,516
+4,470
+6% +$255K 1.02% 34
2018
Q4 		$3.63M Buy
71,046
+2,562
+4% +$130K 0.9% 38
2018
Q3 		$3.98M Buy
68,484
+510
+0.8% +$24.9K 0.87% 39
2018
Q2 		$3.3M Buy
67,974
+2,370
+4% +$111K 0.78% 39
2018
Q1 		$3.05M Buy
65,604
+8,340
+15% +$362K 0.76% 40
2017
Q4 		$2.15M Buy
57,264
+16,920
+42% +$621K 0.54% 47
2017
Q3 		$1.47M Buy
40,344
+21,720
+117% +$828K 0.39% 55
2017
Q2 		$734K Buy
18,624
+11,319
+155% +$413K 0.2% 75
2017
Q1 		$229K Buy
+7,305
New +$229K 0.07% 108

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Bath Savings Trust's EW Position: Q2 2026 in Review

Bath Savings Trust reduced its Edwards Lifesciences (EW) stake by 3.7% in Q2 2026, selling an estimated $26K and leaving 8,055 shares worth $729K. The position accounts for 0.08% of the portfolio, ranked #116.

Bath Savings Trust first reported a position in EW in Q1 2017 and has held it in 38 quarters since. The position peaked at $14.8M in Q4 2021. 287 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Bath Savings Trust held 8,055 shares of Edwards Lifesciences worth $729K as of Q2 2026.
  • Bath Savings Trust sold 310 Edwards Lifesciences shares in Q2 2026, an estimated $26K.
  • Edwards Lifesciences made up 0.08% of Bath Savings Trust's portfolio in Q2 2026, its #116 holding.
  • Bath Savings Trust first reported a position in Edwards Lifesciences in Q1 2017 and has held it in 38 quarters since.
  • Bath Savings Trust's Edwards Lifesciences position peaked at $14.8M in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bath Savings Trust's 13F filing for Q2 2026, filed 9 Jul 2026.